1. Home
  2. INCR vs XTNT Comparison

INCR vs XTNT Comparison

Compare INCR & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intercure Ltd.

INCR

Intercure Ltd.

SELL

Current Price

$5.01

Market Cap

58.6M

Sector

Health Care

ML Signal

SELL

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.32

Market Cap

47.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INCR
XTNT
Founded
1994
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.6M
47.9M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
INCR
XTNT
Price
$5.01
$0.32
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $1.03
AVG Volume (30 Days)
3.5K
★ 169.9K
Earning Date
10-27-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 125.00
EPS
★ N/A
N/A
Revenue
N/A
★ $53,337,000.00
Revenue This Year
$200.38
N/A
Revenue Next Year
N/A
$10.85
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.68
$0.27
52 Week High
$6.10
$0.95

Technical Indicators

Market Signals
Indicator
INCR
XTNT
Relative Strength Index (RSI) 48.39 40.03
Support Level $0.81 $0.32
Resistance Level $5.58 $0.49
Average True Range (ATR) 0.18 0.02
MACD -0.14 -0.00
Stochastic Oscillator 19.51 1.54

Price Performance

Historical Comparison
INCR
XTNT

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Share on Social Networks: